Johnson & Johnson Takes a Notable Stance on Tuberculosis Drug
Johnson & Johnson's important decision not to enforce secondary patents on vital TB treatment and ensure broader availability as cases rise.
Source: camelcitydispatch.com
Stay updated with breaking news from Pharma Otsuka. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Johnson & Johnson's important decision not to enforce secondary patents on vital TB treatment and ensure broader availability as cases rise.